Tuesday, 17 November 2026European Markets

BIOSENIC Stock Went Down By Over 31% In The Last 10 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of BIOSENIC (BEL 20: BIOS.BR) slid by a staggering 31.07% in 10 sessions from €0.19 to €0.13 at 13:10 EST on Monday, after three consecutive sessions in a row of losses. BEL 20 is jumping 0.17% to €3,891.80, following the last session's upward trend.

About BIOSENIC

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BIOSENIC's stock is considered to be overbought (>=80).

Volume

Today's last reported volume for BIOSENIC is 50890 which is 92.64% below its average volume of 298319.

Volatility

BIOSENIC's last week, last month's, and last quarter's current intraday variation average was a negative 6.62%, a positive 1.40%, and a positive 5.85%.

BIOSENIC's highest amplitude of average volatility was 7.15% (last week), 10.89% (last month), and 5.85% (last quarter).

More news about BIOSENIC (BIOS.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 6 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›